{"id":"https://openalex.org/W2902844402","doi":"https://doi.org/10.1182/blood-2018-99-119495","title":"High Efficacy of Lenalidomide Plus R-CHOP (R2CHOP) Combination in First Line Treatment of Activated B-Cell (ABC) DLBCL Defined Using Gene-Expression Prophyling: A Combined Analysis from Two Phase 2 Trials","display_name":"High Efficacy of Lenalidomide Plus R-CHOP (R2CHOP) Combination in First Line Treatment of Activated B-Cell (ABC) DLBCL Defined Using Gene-Expression Prophyling: A Combined Analysis from Two Phase 2 Trials","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2902844402","doi":"https://doi.org/10.1182/blood-2018-99-119495","mag":"2902844402"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-119495","doi":"https://doi.org/10.1182/blood-2018-99-119495","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119495","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020978640","display_name":"Alessia Castellino","orcid":"https://orcid.org/0000-0002-1922-9054","observed_orcids":["https://orcid.org/0000-0002-1922-9054"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessia Castellino","raw_affiliation_strings":["Hematology Department, Citt\u00e0 della Salute e della Scienza, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Citt\u00e0 della Salute e della Scienza, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054623894","display_name":"Annalisa Chiappella","orcid":"https://orcid.org/0000-0002-2977-0098","observed_orcids":["https://orcid.org/0000-0002-2977-0098"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Annalisa Chiappella","raw_affiliation_strings":["Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Azienda Ospedaliero Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044733637","display_name":"Betsy R LaPlant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Betsy Laplant","raw_affiliation_strings":["Mayo Clinic, Biomedical Statistics & Informatics, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Biomedical Statistics & Informatics, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054766520","display_name":"Levy D. Pederson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Levy D. Pederson","raw_affiliation_strings":["Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006640724","display_name":"Giorgio Inghirami","orcid":"https://orcid.org/0000-0001-5566-0864","observed_orcids":["https://orcid.org/0000-0001-5566-0864","https://orcid.org/0000-0002-5298-6516"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Giorgio Inghirami","raw_affiliation_strings":["Weill Cornell Medical College, New York,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College, New York,","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041745367","display_name":"Gianluca Ga\u00efdano","orcid":"https://orcid.org/0000-0002-4681-0151","observed_orcids":["https://orcid.org/0000-0002-4681-0151"]},"institutions":[{"id":"https://openalex.org/I123338534","display_name":"Universit\u00e0 degli Studi del Piemonte Orientale \u201cAmedeo Avogadro\u201d","ror":"https://ror.org/04387x656","country_code":"IT","type":"education","lineage":["https://openalex.org/I123338534"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluca Gaidano","raw_affiliation_strings":["Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy","institution_ids":["https://openalex.org/I123338534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057021891","display_name":"William R. Macon","orcid":"https://orcid.org/0000-0003-4188-823X","observed_orcids":["https://orcid.org/0000-0003-4188-823X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William R Macon","raw_affiliation_strings":["Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076236981","display_name":"Alessandra Tucci","orcid":"https://orcid.org/0000-0003-3052-7463","observed_orcids":["https://orcid.org/0000-0003-3052-7463"]},"institutions":[{"id":"https://openalex.org/I4210103289","display_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","ror":"https://ror.org/015rhss58","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210103289"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alessandra Tucci","raw_affiliation_strings":["Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy","institution_ids":["https://openalex.org/I4210103289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014972717","display_name":"Rebecca L. King","orcid":"https://orcid.org/0000-0002-7132-0226","observed_orcids":["https://orcid.org/0000-0002-7132-0226"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca L King","raw_affiliation_strings":["Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110464585","display_name":"Angela Giovanna Congiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Angela Giovanna Congiu","raw_affiliation_strings":["Department of Hematology, San Martino Hospital and University, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, San Martino Hospital and University, Genova, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025688165","display_name":"Thomas Matthew Habermann","orcid":"https://orcid.org/0000-0003-3532-9132","observed_orcids":["https://orcid.org/0000-0003-3532-9132"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M. Habermann","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004152557","display_name":"Thomas Elmer Witzig","orcid":"https://orcid.org/0000-0002-4215-6500","observed_orcids":["https://orcid.org/0000-0002-4215-6500"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas E. Witzig","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000403848","display_name":"Umberto Vitolo","orcid":"https://orcid.org/0000-0001-7772-2747","observed_orcids":["https://orcid.org/0000-0001-7772-2747"]},"institutions":[{"id":"https://openalex.org/I4210086903","display_name":"Azienda Ospedaliera Citta' della Salute e della Scienza di Torino","ror":"https://ror.org/001f7a930","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210086903"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Umberto Vitolo","raw_affiliation_strings":["Department of Oncology and Hematology, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Hematology, A.O.U. Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy","institution_ids":["https://openalex.org/I4210086903"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061713890","display_name":"Grzegorz S. Nowakowski","orcid":"https://orcid.org/0000-0002-6955-9393","observed_orcids":["https://orcid.org/0000-0002-6955-9393"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grzegorz S. Nowakowski","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5006640724","https://openalex.org/A5020978640","https://openalex.org/A5044733637","https://openalex.org/A5054766520","https://openalex.org/A5057021891","https://openalex.org/A5076236981","https://openalex.org/A5110464585"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210086903","https://openalex.org/I4210103289","https://openalex.org/I4210146472","https://openalex.org/I4387153466"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"2962","last_page":"2962"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8619999885559082},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.7739999890327454},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8820000290870667},{"id":"https://openalex.org/keywords/germinal-center-b-cell-phenotype","display_name":"germinal center B-cell phenotype","score":0.8619999885559082},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cell-of-origin","display_name":"cell of origin","score":0.7979999780654907},{"id":"https://openalex.org/keywords/nanostring","display_name":"NanoString","score":0.6480000019073486},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7960000038146973},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9520000219345093},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6650000214576721},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6930000185966492},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5590000152587891},{"id":"https://openalex.org/keywords/ipi","display_name":"IPI","score":0.31299999356269836},{"id":"https://openalex.org/keywords/relapse-after-remission","display_name":"relapse after remission","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8908001184463501},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.7675058841705322},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6349518895149231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6223477125167847},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.5495365262031555},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5232223868370056},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5147702693939209},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4183264970779419},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.41000816226005554},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3701060116291046},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3292655646800995},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2957540452480316},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.1915559470653534},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18478259444236755}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-119495","doi":"https://doi.org/10.1182/blood-2018-99-119495","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119495","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2588373521","https://openalex.org/W2139836848","https://openalex.org/W3128028170","https://openalex.org/W2603210146","https://openalex.org/W2597427850","https://openalex.org/W2952129287","https://openalex.org/W2951720456","https://openalex.org/W2985160385","https://openalex.org/W3132205831","https://openalex.org/W2900423903"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Lenalidomide":[2],"(Len)":[3],"in":[4,18,66,75,107,132,150,178,202,222,238,250,302,307,315,359,445,501],"association":[5,515],"with":[6,46,111,224,341,364,370,518,533],"standard":[7],"Rituximab-CHOP":[8],"(R2CHOP21)":[9],"has":[10,85],"been":[11,87],"shown":[12],"to":[13,42,61,118,217,232,257,270,521],"be":[14],"safe":[15],"and":[16,115,143,161,171,175,196,204,220,235,240,266,331,367,386,397,429,440,479,494,537],"effective":[17],"newly":[19,125],"diagnosed":[20,126],"Diffuse":[21],"Large":[22],"B-cell":[23,49],"Lymphomas":[24],"(DLBCL)":[25],"[Nowakowski":[26],"et":[27,32],"al.":[28,33],"JCO":[29],"2014,":[30],"Vitolo":[31],"Lancet":[34],"Oncol":[35],"2014].":[36],"The":[37,514],"addition":[38],"of":[39,69,73,94,209,252,275,322,336,345,516,527,562,588,620,633,646,664],"lenalidomide":[40],"appears":[41,520],"benefit":[43],"primarily":[44],"patients":[45,109,130,223,419,423],"non-Germinal":[47],"Center":[48],"(non-GCB)":[50],"phenotype":[51,366,410,529],"as":[52,78],"determined":[53,213,530],"by":[54,80,139,214,228,378,407,450,508,531],"immunohistochemistry":[55],"(IHC).":[56],"These":[57],"early":[58],"results":[59],"led":[60],"currently":[62],"ongoing":[63],"randomized":[64],"trial":[65],"ABC":[67,76,116,267,458,504,528],"subtype":[68],"DLBCL,":[70],"however":[71],"efficacy":[72],"R2CHOP":[74],"DLBCL":[77,108,129,277],"defined":[79,406,449,507],"Gene":[81],"Expression":[82],"Prophyling":[83],"(GEP)":[84],"not":[86,425,475],"reported.":[88],"In":[89,374],"the":[90,102,151,246,523],"present":[91],"combined":[92],"analysis":[93,377],"two":[95,133,152],"independent":[96],"phase":[97,135],"2":[98,136,343],"studies,":[99],"we":[100],"report":[101],"long-term":[103,247,543],"follow-up":[104,321],"(FU)":[105],"outcome":[106,249],"treated":[110],"R2CHOP,":[112],"comparing":[113,263],"GCB":[114,265,365,409,446,456,502],"according":[117,216,231,269],"Nanostring":[119,454],"Platform.":[120],"Methods:":[121],"We":[122,244],"included":[123],"all":[124,159,162],"histologically-confirmed":[127],"de-novo":[128],"enrolled":[131],"R2CHOP21":[134],"trials,":[137],"conducted":[138],"Mayo":[140],"Clinic":[141],"(MC)":[142],"Italian":[144],"Lymphoma":[145],"Foundation":[146],"(FIL).":[147],"Inclusion":[148],"criteria":[149],"trials":[153],"were":[154,283,339,413,424,462,474],"similar,":[155],"main":[156],"differences":[157],"included:":[158],"age":[160,168,289],"International":[163,310],"Prognostic":[164,311],"Index":[165,312],"(IPI)":[166,313],"vs":[167,180,381,390,394,399,411,416,433,437,442,447,457,459,465,468,483,485,489,491,496,498,503,505],"between":[169,264],"60":[170],"80":[172],"years":[173,291,324,356],"old":[174],"IPI":[176,379],">1,":[177],"MC":[179,203,239],"FIL":[181,205,241],"study,":[182,242],"respectively.":[183,207,243,402,452],"All":[184],"pts":[185,278,473],"received":[186],"R-CHOP21":[187,519],"plus":[188],"Len":[189,517],"at":[190,541],"25":[191],"mg/day":[192,198],"for":[193,199,404],"10":[194],"days/cycle":[195,201],"15":[197,469],"14":[200],"trial,":[206],"Cell":[208],"origin":[210],"(COO)":[211],"was":[212,327,357],"IHC,":[215,408,451],"Hans":[218],"algorithm,":[219],"retrospectively,":[221],"available":[225],"pathological":[226],"material,":[227],"Nanostring,":[229,509],"performed":[230],"Scott":[233],"algorithm":[234],"Masque-Soler":[236],"signature":[237],"analyzed":[245],"FU":[248,544],"terms":[251],"progression-free":[253],"survival":[254,261],"(PFS),":[255],"time":[256],"progression":[258],"(TTP),":[259],"overall":[260],"(OS),":[262],"phenotypes":[268],"GEP.":[271],"Results:":[272],"A":[273,334],"total":[274,335],"112":[276],"(63":[279],"MC,":[280],"49":[281],"FIL)":[282],"included.":[284],"Main":[285],"characteristics":[286],"were:":[287,383,388,431,481],"median":[288,320],"69":[290],"(y)":[292],"(range":[293],"22-87),":[294],"male":[295],"65":[296],"(58%)":[297],"pts,":[298],"advanced":[299],"stage":[300],"III-IV":[301],"94":[303],"(84%),":[304],"B":[305],"symptoms":[306],"38":[308],"(34%),":[309],"intermediate-high/high":[314],"71":[316],"(63%).":[317],"At":[318],"a":[319,375,542],"5.1":[323],"(y),":[325],"5y-PFS":[326],"63.5%,":[328],"5y-TTP":[329,385,428,478],"70.1%":[330],"5y-OS":[332,387,430,480],"75.4%.":[333],"32":[337],"relapses":[338],"observed,":[340],"only":[342],"cases":[344,361,363],"Central":[346],"Nervous":[347],"System":[348],"(CNS)":[349],"relapse.":[350],"Late":[351],"relapse":[352],"occurring":[353],"beyond":[354],"3":[355],"observed":[358],"4":[360],"(3":[362],"one":[368],"case":[369],"missing":[371],"COO":[372,405],"data).":[373],"subgroup":[376],"0-2":[380],"3-5":[382],"5y-PFS,":[384,427,477],"69.0%":[389],"59.0%":[391],"(p=0.100),":[392],"73.2%":[393],"67.4%":[395],"(p=0.285)":[396],"82.3%":[398],"70.2%":[400],"(p=0.059),":[401],"Regarding":[403,453],"non-GCB":[412],"45":[414],"(40%)":[415],"41":[417],"(37%)":[418],"respectively;":[420,471],"26":[421],"(23%)":[422],"evaluable.":[426,476],"52.8%":[432],"64.5%":[434],"(p=0.198),":[435],"61.6%":[436],"69.6%":[438],"(p=0.444)":[439],"68.6%":[441],"74.1%":[443],"(p=0.238)":[444],"non-GCB,":[448],"analysis,":[455],"Unclassified":[460],"(Uncl)":[461],"31":[463],"(46%)":[464],"22":[466],"(32%)":[467],"(22%)":[470],"44":[472],"62.3%":[482],"70.8%":[484],"64.2%":[486,492],"(p=0.645),":[487],"68.1%":[488],"79.8%":[490],"(p=0.662)":[493],"76.0%":[495],"74.8%":[497],"79.0%":[499],"(p=0.658)":[500],"Uncl,":[506],"respectively":[510],"(Table1,":[511],"Fig1).":[512],"Conclusions:":[513],"overcome":[522],"negative":[524],"prognostic":[525],"impact":[526],"GEP,":[532],"high":[534],"PFS,":[535],"TTP":[536],"OS":[538],"rate,":[539],"maintained":[540],"analysis.":[545],"Figure":[546,548],"1.":[547,549],"Disclosures":[550],"Chiappella:":[551],"Teva:":[552],"Other:":[553,567,571,575,579,593],"lecture":[554,568,572,576,580,594],"fees;":[555,569,573,577,581],"Janssen:":[556,602],"Membership":[557,583,615,628,641,659],"on":[558,584,616,629,642,660],"an":[559,585,617,630,643,661],"entity's":[560,586,618,631,644,662],"Board":[561,587,619,632,645,663],"Directors":[563,589,621,634,647,665],"or":[564,590,622,635,648,666],"advisory":[565,591,623,636,649,667],"committees,":[566,592,624,637,650,668],"Nanostring:":[570],"Roche:":[574,658],"Amgen:":[578,599],"Celgene:":[582,640],"fees.":[595],"Gaidano:Roche:":[596],"Consultancy,":[597,600,603,606,609,614],"Honoraria;":[598,601,604,607,610],"Gilead:":[605,676],"AbbVie:":[608],"Morphosys:":[611],"Honoraria.":[612],"Witzig:Celgene:":[613],"Research":[625,651,669],"Funding.":[626],"Vitolo:Janssen:":[627],"Speakers":[638,653,656,671,674,677],"Bureau;":[639,654,657,672,675],"Funding,":[652,670],"Takeda:":[655],"Sandoz:":[673],"Bureau.":[678]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-12-11T00:00:00"}